Evogene Ltd. (TLV:EVGN)
173.50
+0.20 (0.12%)
Aug 24, 2026, 11:26 AM IDT
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or -55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
111.96K ILS
Profits / Employee
-714.52K ILS
Market Cap
18.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 52 | -65 | -55.56% | 52 | 0 |
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bonus BioGroup | 42 |
| BioLineRx | 24 |
| Matricelf | 15 |
| Purple Biotech | 10 |
| Geffen Residence & Renewal | 6 |
| XTL Biopharmaceuticals | 5 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
Evogene News
- 5 days ago - Evogene Q2 2026 Deep Dive: EPS Beats, Revenue Down 35% - AlphaStreet
- 5 days ago - Evogene Q2 Loss Narrows As AI Transformation Drives Strategic Progress - Nasdaq
- 5 days ago - Evogene Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Evogene Earnings release: Q2 2026 - Filings
- 5 days ago - Evogene Reports Second Quarter and First Half 2026 Financial Results - PRNewsWire
- 6 days ago - Earnings To Watch: Evogene Ltd (EVGN) Q2 2026 -- GF Value Sees 15% Downside - GuruFocus
- 9 days ago - Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - PRNewsWire
- 24 days ago - Evogene Schedules Second Quarter 2026 Financial Results Release - PRNewsWire